Metraipolis › archive › dc_6ca1465ee2fc

The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant… — Europe PMC PMID:41155800

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41155800
DOI: 10.3390/medicina61101813
License (as archived): solo-consultazione
Archived: 2026-11-09T11:27:52.504Z
SHA-256 of the archived text: 3d197543b31e86516daf68d3652ea0e06c252293419a3e1c6716d6b7141379d3
Stable URL of this page: https://metraipolis.com/documento/dc_6ca1465ee2fc

How to cite

The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant… — Europe PMC PMID:41155800 — Europe PMC (en), https://europepmc.org/article/MED/41155800 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ca1465ee2fc (Metraipolis archive dc_6ca1465ee2fc, sha256 3d197543b31e86516daf68d3652ea0e06c252293419a3e1c6716d6b7141379d3)

BibTeX

@misc{dc6ca1465ee2fc,
  title = {The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant… — Europe PMC PMID:41155800},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155800},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ca1465ee2fc; sha256 3d197543b31e86516daf68d3652ea0e06c252293419a3e1c6716d6b7141379d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155800. Agents can read the archived copy with the MCP tool read_document.